Disease · MONDO_0005021
Trials24
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 7 more are not shown, since the checks do not confirm them.
1 to 20 of 24
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03439514 | A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation | Phase 3 | 77 | 2024-01-09 | Dilated Cardiomyopathy, Lamin A/C Gene Mutation | ARRY-797 | Its record names the disease | ClinicalTrials.gov |
| NCT04572893 | Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities | Phase 2 | 41 | 2025-05-21 | Primary Familial Dilated Cardiomyopathy | DANICAMTIV | Its record names the disease | ClinicalTrials.gov |
| NCT00741156 | The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution | Phase 3 | 12 | 2015-12-18 | Hypertension, Congestive Cardiomyopathy | ENALAPRILAT | Its record names the disease | ClinicalTrials.gov |
| NCT02351856 | A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy | Phase 2 | 8 | 2022-03-31 | LMNA-Related Dilated Cardiomyopathy | ARRY-797 | Its record names the disease | ClinicalTrials.gov |
| NCT07210723 | A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy | Phase 2/3 | 332 | Symptomatic Genetic Dilated Cardiomyopathy | DANICAMTIV | Its record names the disease | ClinicalTrials.gov | |
| NCT06632834 | Outcome-targeted Therapy: Principle and Outcome Evaluation: Clinical Study and Phenotype-genotype Correlation | Phase 2 | 230 | Dilated Cardiomyopathy | SIMVASTATIN | Its record names the disease | ClinicalTrials.gov | |
| NCT06250257 | Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age | Phase 3 | 112 | Dilated Cardiomyopathy | BROMOCRIPTINE | Its record names the disease | ClinicalTrials.gov | |
| NCT02654678 | Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril | Phase 2/3 | 100 | Heart Failure, Dilated Cardiomyopathy, Congenital Heart Disease | ENALAPRIL | Its record names the disease | ClinicalTrials.gov | |
| NCT05193838 | Effect of Allopurinol on Left Ventricular Function in Children With Dilated Cardiomyopathy | 100 | Dilated Cardiomyopathy | ALLOPURINOL | Its record names the disease | ClinicalTrials.gov | ||
| NCT01857856 | PHOspholamban RElated CArdiomyopathy STudy - Intervention | Phase 3 | 84 | Phospholamban R14del Mutation-related Cardiomyopathy | EPLERENONE | Its record names the disease | ClinicalTrials.gov | |
| NCT00505154 | Effect of Rosuvastatin on Left Ventricular Remodeling | Phase 3 | 75 | Dilated Cardiomyopathy | ROSUVASTATIN | Its record names the disease | ClinicalTrials.gov | |
| NCT02652728 | Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy | Phase 2/3 | 50 | Heart Failure, Dilated Cardiomyopathy | ENALAPRIL | Its record names the disease | ClinicalTrials.gov | |
| NCT03779646 | Bisoprolol in DMD Early Cardiomyopathy | Phase 2/3 | 42 | Duchenne Muscular Dystrophy, Cardiomyopathy, Dilated | BISOPROLOL | Its record names the disease | ClinicalTrials.gov | |
| NCT00765518 | Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM) | Phase 2 | 40 | Dilated Cardiomyopathy | IXMYELOCEL-T | Its record names the disease | ClinicalTrials.gov | |
| NCT00501514 | Effects of Growth Hormone on Exercise Capacity | Phase 3 | 22 | Chronic Heart Failure | SOMATROPIN | Its record names the disease | ClinicalTrials.gov | |
| NCT01020968 | Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy | Phase 2 | 22 | Dilated Cardiomyopathy | IXMYELOCEL-T | Its record names the disease | ClinicalTrials.gov | |
| NCT00709163 | Nesiritide - Dilated Cardiomyopathy | Not applicable | 20 | Dilated Cardiomyopathy | NESIRITIDE | Its record names the disease | ClinicalTrials.gov | |
| NCT02057341 | A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy | Phase 2 | 12 | LMNA-Related Dilated Cardiomyopathy | ARRY-797 | Its record names the disease | ClinicalTrials.gov | |
| NCT02133911 | A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy | Phase 2 | 10 | Dilated Cardiomyopathy | RANOLAZINE | Its record names the disease | ClinicalTrials.gov | |
| NCT04405804 | Early Administration of Ivabradine in Children With Heart Failure | Phase 2 | 9 | Acute Heart Failure, Dilated Cardiomyopathy | IVABRADINE | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0005021/trials